Search Results - "NOMURA, Takako"
-
1
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
Published in Scientific reports (11-05-2024)“…Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on…”
Get full text
Journal Article -
2
Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C
Published in Hepatology research (01-07-2019)“…Aim Albumin–bilirubin (ALBI) grade was investigated to predict prognosis of patients with cirrhosis. It was defined using the ALBI score calculated based on…”
Get full text
Journal Article -
3
Cancer Therapy Due to Apoptosis: Galectin-9
Published in International journal of molecular sciences (01-01-2017)“…Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer…”
Get full text
Journal Article -
4
Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients
Published in BMC gastroenterology (01-04-2024)“…Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall…”
Get full text
Journal Article -
5
Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest
Published in Oncology reports (01-11-2017)“…Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely…”
Get full text
Journal Article -
6
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
Published in International journal of oncology (01-07-2014)“…Metformin is a commonly used oral anti-hyperglycemic agent of the biguanide family. Recent studies suggest that metformin may reduce cancer risk and improve…”
Get full text
Journal Article -
7
Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up
Published in Internal Medicine (15-06-2021)“…We treated a 51-year-old Japanese man with chronic hepatitis B (viral load 7.6 LC/mL, genotype C). Hepatitis B virus DNA and HBe antigen were undetectable…”
Get full text
Journal Article -
8
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
Published in International journal of oncology (01-06-2015)“…Galectin-9, a soluble β-galactoside-binding animal lectin, evokes apoptosis in various human cancer cell lines. The galectin-9 antitumor effect against…”
Get full text
Journal Article -
9
Correlation between serum galectin‐9 levels and liver fibrosis
Published in Journal of gastroenterology and hepatology (01-02-2018)“…Background and Aim Chronic liver diseases progress from chronic inflammation to fibrosis to tumorigenesis. Galectin‐9, a β‐galactoside‐specific animal lectin,…”
Get full text
Journal Article -
10
Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study
Published in Oncology letters (01-03-2020)“…Direct acting antivirals (DAA) have recently been developed to treat patients with hepatitis C virus (HCV) infection, and interferon-free DAA treatment has…”
Get full text
Journal Article -
11
Clinical efficacy of free androgen index, a surrogate hallmark of circulating free testosterone level, in male patients with HCV-related chronic liver disease
Published in Journal of Clinical Biochemistry and Nutrition (01-11-2018)“…The role of free testosterone, that not bound to sex hormone-binding globulin, in male patients with HCV infection remains uncertain. We investigated whether…”
Get full text
Journal Article -
12
Galectin-9: An anticancer molecule for gallbladder carcinoma
Published in International journal of oncology (01-03-2016)“…Gallbladder cancer (GBC) is the most common and aggressive type of biliary tract cancer. There are various histological types of GBC, and the vast majority of…”
Get full text
Journal Article -
13
Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV
Published in Internal Medicine (01-01-2018)“…Combination therapy with ledipasvir and sofosbuvir (LDV/SOF), direct-acting antiviral agents, is highly effective against hepatitis C virus genotype 1…”
Get full text
Journal Article -
14
Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients
Published in International journal of molecular sciences (02-07-2018)“…The therapeutic goal for hepatitis B virus (HBV) infection is HBs antigen (HBsAg) seroclearance, which is achieved through 48-week pegylated interferon…”
Get full text
Journal Article -
15
Antitumor effect of metformin in esophageal cancer: In vitro study
Published in International journal of oncology (01-02-2013)“…Recent studies suggest that metformin, which is a member of the biguanide family and commonly used as an oral anti-hyperglycemic agent, may reduce cancer risk…”
Get full text
Journal Article -
16
MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis
Published in International journal of molecular medicine (01-04-2015)“…Non-alcoholic steatohepatitis (NASH) is one of the most common causes of chronic liver disease and is considered to be a causative factor of cryptogenic…”
Get full text
Journal Article -
17
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
Published in Oncology letters (01-08-2020)“…Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Clinical management has improved the prognosis of early HCC, but…”
Get full text
Journal Article -
18
Association between microRNA-527 and glypican-3 in hepatocellular carcinoma
Published in Oncology letters (01-03-2021)“…The present study aimed to identify the specific microRNAs (miRNAs/miRs) and their corresponding target genes involved in hepatocellular carcinomas (HCCs)…”
Get full text
Journal Article -
19
Galectin-9 suppresses the proliferation of gastric cancer cells in vitro
Published in Oncology reports (01-02-2016)“…Gastric cancer is the second-leading cause of cancer-related mortality worldwide, and the prognosis of advanced gastric cancer remains poor. Galectin-9 (Gal-9)…”
Get full text
Journal Article -
20
Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth
Published in International journal of oncology (01-10-2015)“…Although gemcitabine (2′,2′-difluorocytidine monohydrochloride) is a common anticancer agent of cholangiocellular carcinoma (CCC), its growth inhibitory…”
Get full text
Journal Article